AIMed is delighted to launch AIMed Cardiology this Valentine’s Day, to acknowledge American heart month in February. The mission of AIMed has always been bringing physicians, healthcare professionals, business executives and technology experts together. As a platform which relentlessly explore and showcase the potentials of artificial intelligence (AI) and related technology in medicine.
AIMed Cardiology will continue our mission. Between 17 and 18 June at Ritz-Carlton, Chicago, Illinois, attendees will learn more about machine learning (ML) and deep learning (DL)’s impacts on cardiac imaging. The event will also give away snippets of cardiac surgery’s future via the use of virtual reality (VR) and augmented reality (AR). AIMed hopes the initiative will facilitate an understanding of medical education of the future and prepare the industry for precision cardiovascular medicine with AI.
We believe AIMed Cardiology is the number one event of its type in US. The one and a half day conference is devoted to give a firsthand explanation and exhibition of what AI-inspired technology has on cardiology. According to the Centers for Disease Control and Prevention (CDC), an estimated of 610,000 people die of heart disease in the US annually. Of which, 370,000 people are dying of coronary heart disease.
Although the probability of heart disease associated deaths differ across race and ethnicity, the condition itself affects all genders. As many as 735,000 Americans are believed to experience heart attack every year. Most people only recognized chest pain as one of the symptoms but only 27% know of its other symptoms and will promptly react when a cardiac arrest episode occurs.
It’s projected that by 2030, the yearly cardiovascular disease medical cost will be more than $818 billions. The country will lose $275 billions of productivity as a result. Thus, cardiology has created a huge window for AI and technology to step in: to better diagnose, reduce cost and educate patients.
What to look out for?
AI’s impact on cardiology is three-fold. AI-powered monitoring tools enable individuals to keep a record of their heart rates and activities. The collected information, coupled with data from electrocardiogram (ECG), will provide healthcare professionals valuable insights that promote more accurate diagnoses.
On the other hand, AI also permits a better visualization and insights into our hearts in real-time. Last but not least, ML is calculating patients’ risks of having the next heart attack and predicting their success rate in administered therapies and treatments. Overall, the development of AI in cardiology is as exciting as AI in medicine itself.
Regardless of whether you are an expert in the field, AIMed strongly encourage you to come to our AIMed Cardiology event. To move away from the hypes and myths and find out in reality and details, what technology can actually achieve in the area of healthcare.
The AIMed Cardiology event page is now up. Do follow us on Twitter, Instagram, Facebook and Youtube for more upcoming events and updates. We look forward to meeting you at AIMed Cardiology between 17 and 18 June at Ritz-Carlton, Chicago.
A science writer with data background and an interest in current affair, culture and arts; a no-med from an (almost) all-med family. Follow on Twitter.